Edwin Cuperus on LinkedIn: I’m happy to share that I’ve obtained a new certification: Wiley Top… (2024)

This post is unavailable.

• Shawn Kwatra

  Joseph W. Burnett Endowed Professor and Chairman of Dermatology, University of Maryland School of Medicine

  10mo

  • Report this post

  What a huge honor to present at the European Academy of Dermatology and Venereology Meeting’s plenary session to provide the first glimpse of data from a phase 2 trial of abrocitinib in the management of #Prurigo Nodularis and Chronic Pruritus of Unknown Origin. The translational revolution in #itch is advancing rapidly! #EADV2023

  • 
  • 
  • 

  257

  6 Comments

  Like Comment

  To view or add a comment, sign in

• Dermatologi DK

  251 followers

  9mo

  • Report this post

  Ida Vittrup Nielsen, MD and PhD,Department of Dermatology, Bispebjerg Hospital, Denmark, discusses a cross-sectional study on risk factors, presented at EADV 2023, that could affect the use of JAK-inhibitors in Danish patients with atopic dermatitis. The results reveal the prevalence of various risk factors among the patient population and how they influence the choice of JAK-inhibitor treatment.#EADV23 #JAK #AtopicDermatitis

  Risk Factors for JAK-Inhibitor Treatment in Atopic Dermatitis https://bpno.dk

  45

  2 Comments

  Like Comment

  To view or add a comment, sign in

• Dermatologi NO

  See Also

  Secretaresse front office kinderafdeling | Harderwijk | Ziekenhuis St JansdalAangeschreven bekostigde stageaanbieders 2023-2024 - Stagefonds ZorgZiekenhuis St Jansdal on LinkedIn: Vandaag heeft het Moeder&Kind Centrum van ons ziekenhuis twee keurmerken…Ziekenhuis St Jansdal op LinkedIn: Uitlegvideo Transmuraal Overleg Kwetsbare ouderen

  6 followers

  9mo

  • Report this post

  Ida Vittrup, MD and PhD,Department of Dermatology, Bispebjerg Hospital, Denmark, discusses a cross-sectional study on risk factors, presented at EADV 2023, that could affect the use of JAK-inhibitors in Danish patients with atopic dermatitis. The results reveal the prevalence of various risk factors among the patient population and how they influence the choice of JAK-inhibitor treatment.#EADV23 #JAK #AtopicDermatitis

  Risk Factors for JAK-Inhibitor Treatment in Atopic Dermatitis https://bpno.no

  Like Comment

  To view or add a comment, sign in

• Dermatology Times

  27,195 followers

  10mo

  • Report this post

  Rocco Serrao, MD, found his expertise in inflammation, particularly #psoriasis. He delved into the promising data on #bimekizumab at Maui Dermatology NP+PA Fall 2023, shedding light on its potential to block key signaling pathways and achieve impressive PASI scores in phase 3 trials. #DermatologyInnovation #PsoriasisSolutions 🌟🔬https://lnkd.in/gX3ygCXx

  Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval dermatologytimes.com

  51

  Like Comment

  To view or add a comment, sign in

• Dr. Elina Manzhalii, MD, PhD

  MD, PhD, Professor (associate), Bogomolets National Medical University, CEO Global Longevity Institute – Global Longevity

  9mo

  • Report this post

  XVI aesthetic dermatology symposium organized by prof Marina Anfilova. My report was about the causes of skin itching and the causes from the hepatobiliary system

  • 

  4

  Like Comment

  To view or add a comment, sign in

• Dermatologi DK

  251 followers

  9mo

  • Report this post

  In this MEDtalk, Stephan Weidinger, Professor of Dermatology from Kiel, gives his perspective on the importance of Type 2 inflammation and skin barrier deficiency in the development and choice of treatment for patients with atopic dermatitis based on the knowledge of which cytokines are most important for the management of AD.#EADV3 #AtopicDermatitis

  AD: New knowledge about Type 2 inflammation and skin barrier deficiency https://bpno.dk

  1

  Like Comment

  To view or add a comment, sign in

• HCPLive

  3,146 followers

  4mo

  • Report this post

  At the end of #AAD2024, Andrew Alexis, MD, MPH, vice-chair for diversity and inclusion for the department of dermatology and professor of clinical dermatology at Weill Cornell Medicine, discussed the significance of new tapinarof cream findings as they relate to the current state of clinical management of atopic dermatitis skin of color. Alexis additionally talked about what specific clinical and demographic challenges patients of color face in adequately treating chronic skin diseases, and what further steps may his peers take to further improve representation in research and care tailored to skin of color. Read here: https://lnkd.in/e_uCYy4M

  • 

  2

  Like Comment

  To view or add a comment, sign in

• Christophe Hsu (徐華昌)

  Dermatologist - Global Dermatology (Medical Education & Clinical Services)

  8mo Edited

  • Report this post

  This week’s quiz. (Hint below)-https://lnkd.in/etY9xCqQ : Ask anything in Dermatology while at World Psychodermtology Day. Hint: Of historical interest: The term was first coined in 1664 by a Polish physician J.Jonston “Medicina Practica".*Program Highlights: -Patient perspectives, Panel discussions and Presentations -Psychiatric Diseases in Dermatology -Mental Health in Chronic Dermatoses (Acne, Alopecia Areata, Hidradenitis Suppurativa, Psoriasis, Vitiligo) -Psychodermatology in Cosmetic Dermatology -Psychodermatology around the World

  • 

  32

  9 Comments

  Like Comment

  To view or add a comment, sign in

• International Psoriasis Council

  3,702 followers

  8mo Edited

  • Report this post

  Now available: New congress report from the 32nd European Academy of Dermatology and Venereology 2023 Congress (#EADV)!In this report, 2022 IPC Fellow Juul van den Reek has compiled thirteen summaries of the latest and most inspiring presentations on psoriasis at this year’s EADV, including IPC’s symposium and late-breaking sessions. Read the summary or download the full report: https://lnkd.in/g_wx63ZU #IPCCongressReport #PsoriasisNews

  • 

  13

  Like Comment

  To view or add a comment, sign in

• Artax Biopharma Inc

  1,575 followers

  2mo

  • Report this post

  This #FollowFriday, we wanted to spotlight founder and CEO of Dermatology Research and Education Foundation, Jashin Wu, MD, FAAD. Dr. Wu is also Founding Director of Dermatology Research at Kaiser Permanente. Follow Dr. Wu for more information on the latest research around #psoriasis.

  • 

  3

  Like Comment

  To view or add a comment, sign in